​

Xenon Pharmaceuticals Ownership | Who Owns Xenon Pharmaceuticals?

OverviewForecastFinancialsChartTranscripts

Xenon Pharmaceuticals Ownership Summary

Xenon Pharmaceuticals is owned by 96.09% institutional investors, 0.38% insiders, and 3.54% retail investors. Fmr is the largest institutional shareholder, holding 8.72% of XENE shares. American Funds SMALLCAP World A is the top mutual fund, with 6.33% of its assets in Xenon Pharmaceuticals shares.

XENE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXenon Pharmaceuticals96.09%0.38%3.54%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr6.77M8.72%$263.89M
Avoro capital advisors5.67M7.30%$220.94M
Driehaus capital management4.42M5.70%$172.32M
Wellington management group llp3.83M4.93%$149.26M
Commodore capital lp2.75M3.55%$107.39M
Capital world investors2.68M3.46%$104.55M
Braidwell lp2.56M3.30%$99.84M
Polar capital2.54M3.27%$98.88M
Capital investors2.48M3.19%$96.53M
Blackrock2.10M2.70%$81.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp2.75M7.33%$107.39M
Altium capital management lp360.60K5.74%$14.06M
Affinity asset advisors994.23K4.47%$38.76M
First light asset management1.31M4.46%$50.93M
Nan fung group106.68K4.44%$4.16M
Ally bridge group (ny)169.37K3.93%$6.60M
Tls advisors32.96K3.22%$1.28M
Braidwell lp2.56M3.13%$99.84M
Bridger management146.80K2.95%$5.72M
Avoro capital advisors5.67M2.94%$220.94M

Top Buyers

HolderShares% AssetsChange
Braidwell lp2.56M3.13%1.25M
Commodore capital lp2.75M7.33%586.47K
Orbimed advisors862.36K0.67%312.36K
Westfield capital management co lp643.55K0.12%296.19K
Samlyn capital639.68K0.42%243.49K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---2.04M
Lord, abbett190.03K0.02%-705.16K
Great point partners---456.15K
Logos global management lp---375.00K
First turn management339.88K2.16%-340.51K

New Positions

HolderShares% AssetsChangeValue
Thrivent financial for lutherans43.09K0.00%43.09K$1.68M
Skandinaviska enskilda banken ab (publ)40.38K0.01%40.38K$1.57M
Rhenman & partners asset management ab35.00K0.13%35.00K$1.36M
Adar1 capital management4.70K0.03%4.70K$183.25K
Nelson, van denburg & campbell wealth management group2.57K0.00%2.57K$100.70K

Sold Out

HolderChange
Dinuzzo private wealth-2.00
Sjs investment consulting-5.00
Jfs wealth advisors-8.00
Park place capital-18.00
Entrypoint capital-26.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024207-4.17%74,878,3241.04%961.05%91-5.21%61-15.28%
Jun 30, 2024216-3.57%74,109,2450.93%951.07%96-15.79%725.88%
Mar 31, 20242241.36%73,423,1981.98%940.89%114-16.79%6830.77%
Dec 31, 202322113.33%72,000,39717.42%1021.19%13742.71%526.12%
Sep 30, 20231957.73%61,316,223-0.15%921.07%965.49%49-12.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A4.83M6.33%-420.69K
Vanguard Health Care Inv2.54M3.33%-
Polar Capital Biotech S Inc1.75M2.30%-
Fidelity Select Health Care1.25M1.64%-
Fidelity Advisor Health Care I780.00K1.02%-
Strategic Advisers Fidelity US TtlStk724.40K0.95%-
Fidelity Advisor Biotechnology I710.76K0.93%-
Pictet Biotech658.54K0.87%658.54K
Polar Capital Healthcare Opports Inc652.16K0.86%-
Pictet-Biotech P USD636.59K0.83%-20.48K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 27, 2025MORTIMER IAN PRESIDENT & CEOSell$47.19K
Jan 23, 2025MORTIMER IAN PRESIDENT & CEOSell$649.98K
Jan 27, 2025MORTIMER IAN PRESIDENT & CEOSell$613.62K
Jan 24, 2025MORTIMER IAN PRESIDENT & CEOSell$903.21K
Dec 18, 2024AULIN SHERRY Chief Financial OfficerSell$296.81K

Insider Transactions Trends

DateBuySell
2025 Q1-4
2024 Q4-4
2024 Q2--
2024 Q1-7
2023 Q4-5

XENE Ownership FAQ

Who Owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals shareholders are primarily institutional investors at 96.09%, followed by 0.38% insiders and 3.53% retail investors. The average institutional ownership in Xenon Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Xenon Pharmaceuticals falls below.

Who owns the most shares of Xenon Pharmaceuticals?

Xenon Pharmaceuticals’s largest shareholders are Fmr (6.77M shares, 8.72%), Avoro capital advisors (5.67M shares, 7.30%), and Driehaus capital management (4.42M shares, 5.70%). Together, they hold 21.72% of Xenon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Xenon Pharmaceuticals?

Yes, BlackRock owns 2.70% of Xenon Pharmaceuticals, totaling 2.1M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 81.72M$. In the last quarter, BlackRock decreased its holdings by -26.034K shares, a -1.23% change.

Who is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.33% of its assets in 2.75M Xenon Pharmaceuticals shares, valued at 107.39M$.

Who is the top mutual fund holder of Xenon Pharmaceuticals shares?

American Funds SMALLCAP World A is the top mutual fund holder of Xenon Pharmaceuticals shares, with 6.33% of its total shares outstanding invested in 4.83M Xenon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools